FindTrial
Sign In

Analysis of prognostic factors and radiation indication of extranodal mucosa-associated lymphoid tissue lymphoma

Analysis of prognostic factors and radiation indication of extranodal mucosa-associated lymphoid tissue lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102202
Enrollment
Unknown
Registered
2025-05-12
Start date
2023-07-01
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucosa-associated lymphoid tissue (MALT)

Interventions

Cases group:None

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pathologically confirmed extranodal mucosa-associated lymphoid tissue (MALT) lymphoma It was first diagnosed between 2000 and 2020

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactShu-Nan Qi

Cancer Hospital, Chinese Academy of Medical Sciences

medata@163.com+86 132 6900 0328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026